SCHEMBL4806907

SCHEMBL4806907

OCCc1cccc(N2CCCC2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGXT P21549 3/20 0.58
PRMT6 Q96LA8 1/20 0.57
L3MBTL3 Q96JM7 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 2/20 0.49
ALDH1A1 P00352 2/20 0.49
HPGD P15428 2/20 0.49
KMT2A Q03164 2/20 0.49
GAA P10253 1/20 0.49
HSD17B10 Q99714 1/20 0.49
USP2 O75604 1/20 0.48
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.48
BLM P54132 1/20 0.48
MBTD1 Q05BQ5 1/20 0.47
TP53BP1 Q12888 1/20 0.47
CHKA P35790 3/20 0.45
KCNQ2 O43526 1/20 0.44
DRD2 P14416 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5238064 0.86 HTR7 (0.51) AGXTALDH1A1MAPTDRD2DRD3
SCHEMBL3960459 0.85 AGXT (0.62) AGXTPRMT6L3MBTL3L3MBTL1KDM4E
SCHEMBL5686209 0.85 HTR7 (0.57) ALDH1A1MAPTDRD2DRD3HTR7
SCHEMBL6268645 0.84 PRMT6 (0.63) AGXTPRMT6L3MBTL3L3MBTL1KDM4E
Hydrochloric Acid SCHEMBL5673049 0.83 AGXT (0.60) AGXTMEN1ALDH1A1KMT2AMAPT
SCHEMBL10244433 0.82 PRMT6 (0.61) AGXTPRMT6L3MBTL3L3MBTL1KDM4E
SCHEMBL28216220 0.81 AGXT (0.57) AGXTPRMT6L3MBTL3L3MBTL1KDM4E
SCHEMBL2554494 0.80 ALDH1A1 (0.55) AGXTPRMT6L3MBTL3L3MBTL1KDM4E
SCHEMBL27526754 0.80 PRMT6 (0.55) AGXTPRMT6L3MBTL3L3MBTL1KDM4E
SCHEMBL4808902 0.79 L3MBTL3 (0.72) AGXTPRMT6L3MBTL3L3MBTL1MBTD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7320973-B2 Dihydrodiaryloxazepine derivative and pharmaceutical composition containing the same AJINOMOTO CO., INC. (JP) 2008-01-22 US disclosed
US-20040110742-A1 Dihydrodiaryloxazepine derivative and pharmaceutical composition containing the same AJINOMOTO CO., INC. (JP) 2004-06-10 US disclosed
EP-1403258-A1 DIHYDRODIARYLOXAZEPINE DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THE DERIVATIVE Ajinomoto Co., Inc. (JP) 2004-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110742-A1 Dihydrodiaryloxazepine derivative and pharmaceutical composition containing the same CYP3A4, PPARD, CYP4B1 AGXT 2185/4885PRMT6 3517/4885L3MBTL3 4874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.